Cancer treatments can have severe adverse effects on bone health, and can thus increase the risk of fragility fractures both during therapy and in later life. This Review focuses on bone loss caused by breast cancer and prostate cancer treatments, and discusses lifestyle and pharmacological management strategies for reducing fracture risk in these patients.
- Robert E. Coleman
- Emma Rathbone
- Janet E. Brown